Anticoagulant therapies and outcomes in obese patients with acute venous thromboembolism

S Quan, J Smith, C Wu, SL Koshman, B Nguyen… - Thrombosis …, 2020 - Elsevier
Abstract Background Direct oral anticoagulants (DOACs) are recommended in preference to
traditional anticoagulants (LMWH±warfarin) for treating acute venous thromboembolism …

Anticoagulant therapies and outcomes in obese patients with acute venous thromboembolism

S Quan, J Smith, C Wu, SL Koshman… - Thrombosis …, 2020 - pubmed.ncbi.nlm.nih.gov
Background Direct oral anticoagulants (DOACs) are recommended in preference to
traditional anticoagulants (LMWH±warfarin) for treating acute venous thromboembolism …

Anticoagulant therapies and outcomes in obese patients with acute venous thromboembolism

S Quan, J Smith, C Wu, SL Koshman, B Nguyen… - Thrombosis …, 2020 - elibrary.ru
Background: Direct oral anticoagulants (DOACs) are recommended in preference to
traditional anticoagulants (LMWH+/-warfarin) for treating acute venous thromboembolism …

Anticoagulant therapies and outcomes in obese patients with acute venous thromboembolism

S Quan, J Smith, C Wu, SL Koshman… - Thrombosis …, 2020 - thrombosisresearch.com
Abstract Background Direct oral anticoagulants (DOACs) are recommended in preference to
traditional anticoagulants (LMWH±warfarin) for treating acute venous thromboembolism …

Anticoagulant therapies and outcomes in obese patients with acute venous thromboembolism.

S Quan, J Smith, C Wu, SL Koshman… - Thrombosis …, 2020 - europepmc.org
Background Direct oral anticoagulants (DOACs) are recommended in preference to
traditional anticoagulants (LMWH±warfarin) for treating acute venous thromboembolism …

Anticoagulant therapies and outcomes in obese patients with acute venous thromboembolism

S Quan, J Smith, C Wu, SL Koshman… - Thrombosis …, 2020 - thrombosisresearch.com
Abstract Background Direct oral anticoagulants (DOACs) are recommended in preference to
traditional anticoagulants (LMWH±warfarin) for treating acute venous thromboembolism …